Differences in mean number of papers (top) and co-authors (bottom) depending on (1) NI membership and (2) time joined NI. by William C. Barley (8915282)

PAP I point mutations lead to a decrease in pYV PCN, plasmid stability, and T3SS activity. by Katherine Schubert (5452712)

Mean 0-30 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI). by Murat Tutar (22250461)

Mean 0-20 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI). by Murat Tutar (22250461)

Mean 0-10 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI). by Murat Tutar (22250461)

List of Included studies. by Zahra Tajik (20752452)

“…Following the NSPT, the mean visfatin level of GCF, serum and saliva decreases, and in longer follow up time, the level of visfatin decreases significantly. …”

The search strategy in three databases. by Zahra Tajik (20752452)

“…Following the NSPT, the mean visfatin level of GCF, serum and saliva decreases, and in longer follow up time, the level of visfatin decreases significantly. …”

A summary of the included study characteristics. by Zahra Tajik (20752452)

“…Following the NSPT, the mean visfatin level of GCF, serum and saliva decreases, and in longer follow up time, the level of visfatin decreases significantly. …”

NIH score. by Zahra Tajik (20752452)

“…Following the NSPT, the mean visfatin level of GCF, serum and saliva decreases, and in longer follow up time, the level of visfatin decreases significantly. …”

List of excluded studies. by Zahra Tajik (20752452)

“…Following the NSPT, the mean visfatin level of GCF, serum and saliva decreases, and in longer follow up time, the level of visfatin decreases significantly. …”

Data for the G7 countries in 2022. by Luis Alberiko Gil-Alana (14659817)

“…For the rest of the countries, the time trend is insignificant. Dealing with persistence, Japan is the only country that shows clear evidence of reversion to the mean. …”

nsP4-C483Y or Q192L mutations decrease sensitivity to 4′-FlU. by Peiqi Yin (6533747)

Time course of central retinal thickness (CRT) in all eyes. by Yasuyuki Sotani (20114144)

Related inflammation evaluation indexes before and after operation (mean±standard deviation). by Na Wang (193263)

Baseline data of each group (mean±standard deviation)/n (%)/(M(IQR)). by Na Wang (193263)

Time course of best-corrected visual acuity (BCVA) in all eyes. by Yasuyuki Sotani (20114144)

Change in Mean Anxiety Scores Over time by group. by Shaaista Budhani (21030221)

Relevant follow-up evaluation indicators after operation (mean±standard deviation)/n (%). by Na Wang (193263)

Time course of central retinal thickness (CRT) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

Average days (mean) to heal a wound in 2022 and 2023. by Heba Tallah Mohammed (2822432)